Extremely significant negative changes in Amedisys Inc (NASDAQ: AMED) investment behavior have recently occurred: negative upside/downside volume developed, and the stock fell on very heavy volume.
Amedisys Inc (NASDAQ: AMED). Important negative changes in fundamentals have recently occurred: significant quarterly sales deceleration occurred, and the consensus estimate for December, 2025 decreased significantly.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Amedisys has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Amedisys has a slightly negative Appreciation Score of 35 but a slightly positive Power Rating of 61, and the Low Neutral Value Trend Rating results.
Recent Price Action
Amedisys Inc (NASDAQ: AMED) stock closed at $86.27 on 12/3/24 after a large decline of -5.4%. Moreover, trading volume in this decline was exceptionally high at 427% of normal. The stock has declined -4.8% during the last week and has performed in line with the market over the last nine months.
Be the first to comment